Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124782934 | 12478293 | 4 | F | 20160401 | 20160712 | 20160617 | 20160720 | PER | US-JAZZ-2016-US-010941 | JAZZ | 29.74 | YR | F | Y | 0.00000 | 20160720 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124782934 | 12478293 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, BID | Y | Y | 21196 | 3 | G | ORAL SOLUTION | |||||
| 124782934 | 12478293 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.25 G, BID | Y | Y | 21196 | 2.25 | G | ORAL SOLUTION | |||||
| 124782934 | 12478293 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | DOSE ADJUSTMENTS | Y | Y | 21196 | ORAL SOLUTION | |||||||
| 124782934 | 12478293 | 4 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, BID | Y | Y | 21196 | 3 | G | ORAL SOLUTION | |||||
| 124782934 | 12478293 | 5 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.75 G, BID | Y | Y | 21196 | 2.75 | G | ORAL SOLUTION | |||||
| 124782934 | 12478293 | 6 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, 1ST DOSE | Y | Y | 21196 | 3 | G | ORAL SOLUTION | |||||
| 124782934 | 12478293 | 7 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.75 G, 2ND DOSE | Y | Y | 21196 | 2.75 | G | ORAL SOLUTION | |||||
| 124782934 | 12478293 | 8 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.5 G, BID | Y | Y | 21196 | 2.5 | G | ORAL SOLUTION | |||||
| 124782934 | 12478293 | 9 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | UNK | U | 0 | DROP | |||||||||
| 124782934 | 12478293 | 10 | C | ADDERALL XR | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | UNK | U | 0 | CAPSULE | |||||||||
| 124782934 | 12478293 | 11 | C | NUVIGIL | ARMODAFINIL | 1 | UNK | U | 0 | TABLET | |||||||||
| 124782934 | 12478293 | 12 | C | COENZYME Q10 | UBIDECARENONE | 1 | UNK | U | 0 | ||||||||||
| 124782934 | 12478293 | 13 | C | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | UNK | U | 0 | CAPSULE | |||||||||
| 124782934 | 12478293 | 14 | C | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | U | 0 | CAPSULE | ||||||||||
| 124782934 | 12478293 | 15 | C | Fish oil concentrate | 2 | UNK | U | 0 | |||||||||||
| 124782934 | 12478293 | 16 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | UNK | U | 0 | CAPSULE | |||||||||
| 124782934 | 12478293 | 17 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | UNK | U | 0 | TABLET | |||||||||
| 124782934 | 12478293 | 18 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | UNK | U | 0 | TABLET | |||||||||
| 124782934 | 12478293 | 19 | C | Prazosin | PRAZOSIN | 1 | U | 0 | CAPSULE | ||||||||||
| 124782934 | 12478293 | 20 | C | Atorvastatin | ATORVASTATIN | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124782934 | 12478293 | 1 | Narcolepsy |
| 124782934 | 12478293 | 2 | Cataplexy |
| 124782934 | 12478293 | 9 | Vitamin D decreased |
| 124782934 | 12478293 | 10 | Product used for unknown indication |
| 124782934 | 12478293 | 11 | Product used for unknown indication |
| 124782934 | 12478293 | 12 | Supplementation therapy |
| 124782934 | 12478293 | 13 | Anxiety |
| 124782934 | 12478293 | 14 | Depression |
| 124782934 | 12478293 | 15 | Supplementation therapy |
| 124782934 | 12478293 | 16 | Gastrooesophageal reflux disease |
| 124782934 | 12478293 | 17 | Thyroid disorder |
| 124782934 | 12478293 | 18 | Vitamin B12 decreased |
| 124782934 | 12478293 | 19 | Product used for unknown indication |
| 124782934 | 12478293 | 20 | Blood cholesterol increased |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124782934 | 12478293 | Nausea | |
| 124782934 | 12478293 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124782934 | 12478293 | 1 | 20160401 | 20160402 | 0 | |
| 124782934 | 12478293 | 2 | 20160404 | 2016 | 0 | |
| 124782934 | 12478293 | 3 | 2016 | 2016 | 0 | |
| 124782934 | 12478293 | 4 | 2016 | 2016 | 0 | |
| 124782934 | 12478293 | 5 | 2016 | 2016 | 0 | |
| 124782934 | 12478293 | 6 | 2016 | 0 | ||
| 124782934 | 12478293 | 7 | 2016 | 0 | ||
| 124782934 | 12478293 | 8 | 2016 | 0 | ||
| 124782934 | 12478293 | 9 | 201603 | 0 | ||
| 124782934 | 12478293 | 10 | 201603 | 0 | ||
| 124782934 | 12478293 | 11 | 201601 | 0 | ||
| 124782934 | 12478293 | 12 | 201512 | 0 | ||
| 124782934 | 12478293 | 13 | 201512 | 0 | ||
| 124782934 | 12478293 | 15 | 201512 | 0 | ||
| 124782934 | 12478293 | 16 | 201512 | 0 | ||
| 124782934 | 12478293 | 17 | 201512 | 0 | ||
| 124782934 | 12478293 | 18 | 201512 | 0 |